132
Participants
Start Date
August 31, 2011
Primary Completion Date
August 31, 2013
Study Completion Date
August 31, 2013
Hypoglossal Nerve Stimulation (HGNS) System (Apnex Medical )
The HGNS System in an investigational device that includes three implantable components: a neurostimulator, a stimulation lead, and a respiration sensing lead. The HGNS System is designed to activate the muscles in the upper airway to help keep the airway open during sleep. The HGNS System is intended for the treatment of moderate to severe OSA in individuals that have failed or do not tolerate positive airway pressure (PAP) therapy.
Westmead Hospital, Sydney
IBAS, The Austin Hospital, Melbourne
Clinilabs, New York
The Center for Sleep and Wake Disorders, Chevy Chase
Wilmington Medical Research, Wilmington
Sleep Med of South Carolina, Columbia
Kentucky Research Group, Louisville
Community Research, Cincinnati
Henry Ford Hospital, Detroit
University of Minnesota, Minneapolis
St. Lukes Hospital, St Louis
MidAmerica Neuroscience Research Institute, Lenexa
Veritas Clinical Specialties, Topeka
Sleep Therapy and Research Center, San Antonio
Lead Sponsor
Apnex Medical, Inc.
INDUSTRY